Augmentin Dosing
For adults with normal renal function, the standard dose is 500 mg/125 mg three times daily or 875 mg/125 mg twice daily; for children ≥3 months, the standard dose is 45 mg/kg/day of the amoxicillin component divided twice daily, or high-dose 90 mg/kg/day (maximum 4 g/day) divided twice daily for resistant organisms or severe infections. 1
Adult Dosing
Standard Dosing (Normal Renal Function)
- Community-acquired infections (mild-moderate): 500 mg/125 mg PO three times daily OR 875 mg/125 mg PO twice daily 2
- High-dose regimen (resistant pathogens): 2,000 mg/125 mg PO twice daily (extended-release formulation) 3, 1
- Severe infections: Up to 4 g/day of amoxicillin component with 250 mg clavulanate 3
Renal Impairment Adjustments
For creatinine clearance <30 mL/min: Dosing frequency must be reduced 4, 5
- The amoxicillin component accumulates more significantly than clavulanate in renal failure
- CrCl 10-30 mL/min: 500 mg/125 mg every 12-24 hours
- Hemodialysis patients: 500 mg/125 mg after each dialysis session 5
- Both amoxicillin and clavulanate are significantly removed by hemodialysis (approximately 64-65% fractional removal) 5
- Administer supplemental dose after dialysis
Critical caveat: The ratio of amoxicillin to clavulanate increases dramatically with worsening renal function (from 4.9:1 at normal function to 14.7:1 in hemodialysis patients), which maintains adequate clavulanate levels while preventing amoxicillin toxicity 4
Pediatric Dosing
Standard Dosing (≥3 months old)
Mild infections without recent antibiotic use:
High-dose regimen (indicated for):
- Age <2 years
- Daycare attendance
- Recent antibiotic use (within 4-6 weeks)
- Moderate-severe illness
- Geographic areas with >10% penicillin-resistant S. pneumoniae 6
High-dose: 90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate, divided every 12 hours (maximum 4 g amoxicillin/day) 6, 1
Specific Formulations
AUGMENTIN ES-600 (for resistant organisms):
- 90 mg/kg/day divided every 12 hours for 10 days 1
- Provides 600 mg amoxicillin/42.9 mg clavulanate per 5 mL
- Not interchangeable with other Augmentin suspensions due to different clavulanate ratios 1
- Maximum weight: 40 kg (use adult formulations beyond this) 1
Age-Specific Considerations
Infants <3 months: Limited safety data; use only when benefits outweigh risks 1
Critically ill children: May require increased dosing due to augmented renal clearance
- Standard dosing often results in subtherapeutic levels 7
- Consider 25 mg/kg every 4 hours (rather than every 6 hours) with 1-hour infusion for severe sepsis 7
Clinical Context by Indication
Community-Acquired Pneumonia
Children: 90 mg/kg/day (amoxicillin component) divided twice daily for β-lactamase producing H. influenzae 8
Adults with comorbidities: 875 mg/125 mg twice daily OR 2,000 mg/125 mg twice daily combined with a macrolide 2
Acute Bacterial Sinusitis
Children:
- Standard: 45 mg/kg/day divided twice daily
- High-dose: 90 mg/kg/day divided twice daily for moderate-severe disease 6
Adults: 2,000 mg/125 mg twice daily (extended-release) for 10 days 3
Skin and Soft Tissue Infections
Children: 25 mg/kg/day (amoxicillin component) divided twice daily 9
Adults: 875 mg/125 mg twice daily 9
Intra-Abdominal Infections (Pediatric)
200 mg/kg/day of ampicillin component (for ampicillin-sulbactam) divided every 6 hours IV 10
Important Clinical Pitfalls
Formulation confusion: ES-600 suspension contains different clavulanate ratios than standard suspensions and cannot be substituted 1
Renal dosing: Failure to adjust for renal impairment leads to amoxicillin accumulation and increased adverse events 4
Recent evidence challenge: A 2023 large cohort study found no difference in treatment failure between amoxicillin-clavulanate vs amoxicillin alone for pediatric sinusitis, but amoxicillin-clavulanate had higher rates of GI symptoms (RR 1.15) and yeast infections (RR 1.33) 11. This suggests reserving amoxicillin-clavulanate for true β-lactamase-producing organisms rather than empiric use.
Duration: For protracted bacterial bronchitis, 4 weeks provides longer time to next exacerbation compared to 2 weeks, though clinical cure rates at day 28 are similar 12
Administration timing: Give at the start of meals to minimize GI intolerance and enhance clavulanate absorption 1